Uterine vaccination

Biological assay (bioassay) is the process by which the activity of a substance (identified or unidentified) is measured on living material e.g. contraction of bronchial, uterine or vascular muscle. It is used only when chemical or physical methods are not practicable as in the case of a mixture of active substances, or of an incompletely purified preparation, or where no chemical method has been developed. The activity of a preparation is expressed relative to that of a standard preparation of the same substance. Biological standardisation is a specialised form of bioassay. It involves matching of material of unknown potency with an International or National Standard with the objective of providing a preparation for use in therapeutics and research. The results are expressed as units of a substance rather than its weight, e.g. insulin, vaccines. 

ViraUy induced (exogenous) cancers (hepatocellular carcinoma hepatitis C virus-induced squamous cell carcinoma of the uterine cervix or oral cavity (HPV-induced) are preventable with vaccines-induced immunity. The exogenously enforced virally induced cancers are reacted to with the induction of strong host immune defense, whereas the endogenously induced cancers often receive support from the subverted host, a reaction that a cancer vaccine is expected to break and reverse [1994-2000]. Some cancer vaccines caused tumor enhancement. Many cancer vaccines failed [2001a]. It is not clear at all what purpose the new review Cancer Vaccines served [2001b]. 

---